These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex]. Caen JP, Rosa JP, Soria C, Boizard B. C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690 [Abstract] [Full Text] [Related]
9. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin. Yokoyama K, Handa M, Oda A, Katayama M, Fujimura Y, Murata M, Kawai Y, Watanabe K, Ikeda Y. Biochem Biophys Res Commun; 1997 May 08; 234(1):147-52. PubMed ID: 9168979 [Abstract] [Full Text] [Related]
10. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. Osdoit S, Rosa JP. J Biol Chem; 2001 Mar 02; 276(9):6703-10. PubMed ID: 11084040 [Abstract] [Full Text] [Related]
12. Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization. Mondoro TH, White MM, Jennings LK. Blood; 2000 Oct 01; 96(7):2487-95. PubMed ID: 11001901 [Abstract] [Full Text] [Related]
13. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa. Rand ML, Packham MA, Taylor DM, Yeo EL, Gemmell CH, Patil S, Lam SC. Thromb Haemost; 1999 Dec 01; 82(6):1680-6. PubMed ID: 10613655 [Abstract] [Full Text] [Related]